


| Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia |
|
NEW YORK – Singaporean molecular diagnostics company MirXes believes the results of a new clinical validation study will lead to wide uptake of GastroClear, its blood-based quantitative PCR test for the detection of gastric or stomach cancer.
The COVID-19 pandemic created a paradigm shift in modern....
Posted: 2020-11-04 23:23:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.